Consun Pharmaceutical Group Limited

SEHK:1681 Stock Report

Market Cap: HK$5.0b

Consun Pharmaceutical Group Balance Sheet Health

Financial Health criteria checks 6/6

Consun Pharmaceutical Group has a total shareholder equity of CN¥3.9B and total debt of CN¥503.4M, which brings its debt-to-equity ratio to 12.8%. Its total assets and total liabilities are CN¥5.5B and CN¥1.6B respectively. Consun Pharmaceutical Group's EBIT is CN¥825.9M making its interest coverage ratio -17.3. It has cash and short-term investments of CN¥3.6B.

Key information

12.8%

Debt to equity ratio

CN¥503.42m

Debt

Interest coverage ratio-17.3x
CashCN¥3.58b
EquityCN¥3.92b
Total liabilitiesCN¥1.59b
Total assetsCN¥5.51b

Recent financial health updates

Recent updates

Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Jun 01
Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30

Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

May 04
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet

Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Apr 28
Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20

Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Apr 07
Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20

Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Aug 26
Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Apr 21
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly

Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Mar 17
Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?

Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

Feb 19
Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative

How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Jan 29
How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?

Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Jan 08
Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?

Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Dec 18
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly

Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

Nov 18
Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?

Financial Position Analysis

Short Term Liabilities: 1681's short term assets (CN¥4.3B) exceed its short term liabilities (CN¥1.5B).

Long Term Liabilities: 1681's short term assets (CN¥4.3B) exceed its long term liabilities (CN¥94.3M).


Debt to Equity History and Analysis

Debt Level: 1681 has more cash than its total debt.

Reducing Debt: 1681's debt to equity ratio has reduced from 15.7% to 12.8% over the past 5 years.

Debt Coverage: 1681's debt is well covered by operating cash flow (162.7%).

Interest Coverage: 1681 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.